NORISODRINE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Norisodrine, and what generic alternatives are available?
Norisodrine is a drug marketed by Abbvie and Abbott and is included in two NDAs.
The generic ingredient in NORISODRINE is isoproterenol hydrochloride. There are seventeen drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the isoproterenol hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Norisodrine
A generic version of NORISODRINE was approved as isoproterenol hydrochloride by NEXUS on August 2nd, 2017.
Summary for NORISODRINE
US Patents: | 0 |
Applicants: | 2 |
NDAs: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 62 |
Patent Applications: | 3,722 |
Formulation / Manufacturing: | see details |
DailyMed Link: | NORISODRINE at DailyMed |
US Patents and Regulatory Information for NORISODRINE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Abbvie | NORISODRINE | isoproterenol sulfate | POWDER;INHALATION | 006905-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Abbvie | NORISODRINE | isoproterenol sulfate | POWDER;INHALATION | 006905-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Abbott | NORISODRINE AEROTROL | isoproterenol hydrochloride | DISC;INHALATION | 016814-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |